Study identifies the DNA roots of resistance to targeted cancer therapy

A new clinical and preclinical study from UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy, providing a possible strategy to address a vexing issue in cancer therapeutics.

Related Keywords

United States ,American ,Prashanthi Dharanipragada ,Stergios Moschos ,Gatien Moriceau ,Xiao Zhang ,Emily Henderson ,American Association For Cancer Research ,University Of North Carolina At Chapel Hill ,David Geffen School Of Medicine ,Jonsson Comprehensive Cancer Center ,Comprehensive Cancer Center ,Cancer Discovery ,American Association ,David Geffen School ,Industry Focus ,North Carolina ,Chapel Hill ,Cancer ,Cancer Therapy ,Clinical Trial ,Na ,Revolution ,Gene ,Enetic ,Enome ,Enomic ,Medicine ,Melanoma ,Harmacology ,Reclinical ,Research ,Herapeutics ,Humor ,